Skip to main content Accessibility help
  • Print publication year: 2015
  • Online publication date: August 2015

6 - Antithrombotic management of recurrent atherothrombotic cerebrovascular disease

1.Johnston, SC, Nguyen-Huynh, MN, Schwarz, ME, et al. National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol 2006;60(3):301–13.
2.Johnston, S, Rothwell, PM, Nguyen-Huynh, MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007;369(9558):283–92.
3.Lovett, JK, Gallagher, PJ, Hands, LJ, et al. Histological correlates of carotid plaque surface morphology on lumen contrast imaging. Circulation 2004;110(15):2190–7.
4.Johnston, SC, Gress, DR, Browner, WS, Sidney, S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284(22):2901–6.
5.Lovett, JK, Coull, AJ, Rothwell, PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004;62(4):569–73.
6.Ois, A, Gomis, M, Rodríguez-Campello, A, et al. Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke. Stroke 2008;39(6):1717–21.
7.Eliasziw, M, Streifler, JY, Fox, AJ, et al. Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial. Stroke 1994;25(2):304–8.
8.Coutts, SB, Modi, J, Patel, SK, et al. CT/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke. Results of the Prospective CATCH Study. Stroke 2012;43(4):1013–17.
9.Rothwell, PM, Eliasziw, M, Gutnikov, SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361(9352):107–16.
10.Suri, MFK, Johnston, SC Epidemiology of intracranial stenosis. J Neuroimaging 2009;19(S1):11S16S.
11.Lau, AY, Wong, KSL, Lev, M, et al. Burden of intracranial steno-occlusive lesions on initial computed tomography angiography predicts poor outcome in patients with acute stroke. Stroke 2013;44(5):1310–16.
12.Back, MR, Wilson, JS, Rushing, G, et al. Magnetic resonance angiography is an accurate imaging adjunct to duplex ultrasound scan in patient selection for carotid endarterectomy. J Vasc Surg 2000;32(3):429–40.
13.Chaturvedi, S, Bruno, A, Feasby, T, et al. Carotid endarterectomy – an evidence-based review. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005;65(6): 794801.
14.Jung, JM, Kang, DW, Yu, KH, et al. Predictors of recurrent stroke in patients with symptomatic intracranial arterial stenosis. Stroke 2012;43(10):2785–7.
15.Gorelick, PB, Wong, KS, Bae, HJ, Pandey, DK. Large artery intracranial occlusive disease a large worldwide burden but a relatively neglected frontier. Stroke 2008;39(8):2396–9.
16.Degnan, AJ, Gallagher, G, Teng, Z, et al. MR angiography and imaging for the evaluation of middle cerebral artery atherosclerotic disease. Am J Neuroradiol 2012;3(8):1427–35.
17.Chimowitz, MI, Lynn, MJ, Derdeyn, CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365(11):9931003.
18.The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996 ;334:1216–21.
19.Di Tullio, MR, Sacco, RL, Homma, S. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996;335(1464):1464–5.
20.Barazangi, N, Wintermark, M, Lease, K, et al. Comparison of computed tomography angiography and transesophageal echocardiography for evaluating aortic arch disease. J Stroke Cerebrovasc Dis 2011;20 (5):436–42.
21.Ko, Y, Park, JH, Yang, MH, et al. Significance of aortic atherosclerotic disease in possibly embolic stroke: 64-multidetector row computed tomography study. J Neurol 2010;257(5):699705.
22.Amarenco, P, Davis, S, Jones, EF, et al. Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke 2014;45(5):1248–57.
23.George, PM, Albers, GW. Aortic Arch Atheroma A Plaque of a Different Color or More of the Same?. Stroke 2014;45(5):1239–40.
24.Tunick, PA, Nayar, AC, Goodkin, GM, et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol 2002;90(12):1320–5.
25.Hiratzka, LF, Bakris, GL, Beckman, JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. J Am Coll Cardiol 2010;55(14):e27e129.
26.Brandt, T, Steinke, W, Thie, A, et al. Posterior cerebral artery territory infarcts: clinical features, infarct topography, causes and outcome 1. Cerebrovasc Dis 2000;10(3):170–82.
27.Park, KC, Yoon, SS, Rhee, HY. Executive dysfunction associated with stroke in the posterior cerebral artery territory. J Clin Neurosci 2011;18(2):203–8.
28.Arboix, A, Besses, C, Acín, P, et al. Ischemic stroke as first manifestation of essential thrombocythemia. Report of six cases. Stroke 1995;26(8):1463–6.
29.Bleeker, JS, Hogan, WJ. Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies. Thrombosis 2011, Article ID 536062.
30.Cortelazzo, S, Finazzi, G, Ruggeri, M, et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med 1995;332(17):1132–7.
31.Krinsky, GA, Freedberg, R, Lee, VS, et al. Innominate artery atheroma: a lesion seen with gadolinium-enhanced MR angiography and often missed by transesophageal echocardiography. Clin Imaging 2001;25(4):2517.